Food and Drug Administration import alerts on the following have been modified in the past week

- cosmetics that are adulterated and/or misbranded due to color additive violations

- foods containing illegal and/or undeclared colors

- papaya from Mexico

- all vegetable protein products from China for animal or human food use

- processed human and animal foods

- medical devices from firms that have not met device quality system requirements

- pig ears and other pet treats

- animal feeds other than pet treats

- mushrooms from Hong Kong and China

- raw and cooked shrimp from India

- fresh cilantro from the state of Puebla, Mexico

- surgeon’s and patient examination gloves

- candy pacifiers

- coconut

- tamarind products (fresh and/or processed) from all shippers from all countries

- medical instruments from Pakistan

- ceramicware

[Click here for ST&R’s on-demand webinar on how to avoid costs and delays from FDA import alerts.] 

Importers of FDA-regulated goods are responsible for ensuring that such imports are in compliance with FDA laws and regulations. Before shipping into the U.S., importers should be aware of whether or not their product is listed on an import alert. 

Import alerts inform FDA field staff that the agency has enough evidence or other information to allow a product that appears to be in violation of FDA laws and regulations to be detained without physical examination at the time of entry. Import alerts may cover products from designated countries or areas (including from all foreign countries), manufacturers, or shippers. 

Firms and/or products on the “red list” of an import alert are subject to DWPE, while firms and/or products on the “green list” are not because they have met the criteria for exclusion. Some import alerts include a “yellow list” of firms, products, and/or countries subject to intensified surveillance because the nature of the violations may warrant further field examinations of individual entries and/or additional analyses. In addition, depending on the specific import alert, shipments of products subject to DWPE may still be imported into the U.S. if the importer has demonstrated that the shipment is in compliance.  

If a product is detained without physical examination the importer has the right to provide evidence to the FDA in an attempt to overcome the appearance of the violation. If no such evidence is submitted, or if the evidence provided is insufficient to overcome the appearance of the violation, the product will be subject to refusal of entry into the U.S.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.